Hunan Jingfeng Pharmaceutical Cash Flow Conversion Efficiency

Latest as of September 2025: -3.332x

Hunan Jingfeng Pharmaceutical cash flow conversion efficiency. Based on the latest financial reports, Hunan Jingfeng Pharmaceutical (000908) has a cash flow conversion efficiency ratio of -3.332x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥125.78 Million ≈ $18.41 Million USD) by net assets (CN¥-37.76 Million ≈ $-5.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Hunan Jingfeng Pharmaceutical (1999–2024)

Cash flow conversion efficiency of Hunan Jingfeng Pharmaceutical from 1999 to 2024. This chart illustrates how Hunan Jingfeng Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Hunan Jingfeng Pharmaceutical stock quote for real-time trading data and today's change.

Hunan Jingfeng Pharmaceutical Cash Flow Conversion Ratio Explained

Hunan Jingfeng Pharmaceutical cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Hunan Jingfeng Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hunan Jingfeng Pharmaceutical ranked by their cash flow conversion efficiency. Also see 000908 market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Bestsun Energy Co Ltd SHG:600681	0.028x
Yutong Heavy Industries Co Ltd SHG:600817	-0.036x
Jiangsu Jujie Microfiber Technology SHE:300819	0.079x
Sapphire Foods India Limited NSE:SAPPHIRE	0.153x
Ningbo Bohui Chemical Technology SHE:300839	-0.139x
Sunac China Holdings Limited F:SCNR	-0.097x
Global Mixed-Mode Technology Inc TW:8081	0.069x
Charter Hall Social Infrastructure REIT AU:CQE	0.011x

Annual Cash Flow Conversion Efficiency for Hunan Jingfeng Pharmaceutical (1999–2024)

The table below shows the annual cash flow conversion efficiency of Hunan Jingfeng Pharmaceutical from 1999 to 2024. Review Hunan Jingfeng Pharmaceutical free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥-15.13 Million ≈ $-2.21 Million	CN¥-5.55 Million ≈ $-812.28K	0.367x	+260.81%
2023-12-31	CN¥-153.68 Million ≈ $-22.49 Million	CN¥35.06 Million ≈ $5.13 Million	-0.228x	-139.76%
2022-12-31	CN¥214.83 Million ≈ $31.44 Million	CN¥123.27 Million ≈ $18.04 Million	0.574x	+51.85%
2021-12-31	CN¥327.73 Million ≈ $47.96 Million	CN¥123.83 Million ≈ $18.12 Million	0.378x	+188.76%
2020-12-31	CN¥638.18 Million ≈ $93.39 Million	CN¥-271.68 Million ≈ $-39.76 Million	-0.426x	-2385.47%
2019-12-31	CN¥1.94 Billion ≈ $284.15 Million	CN¥36.17 Million ≈ $5.29 Million	0.019x	-84.81%
2018-12-31	CN¥2.86 Billion ≈ $418.81 Million	CN¥350.94 Million ≈ $51.35 Million	0.123x	+110.21%
2017-12-31	CN¥2.60 Billion ≈ $380.45 Million	CN¥151.65 Million ≈ $22.19 Million	0.058x	+1136.37%
2016-12-31	CN¥2.61 Billion ≈ $382.27 Million	CN¥12.32 Million ≈ $1.80 Million	0.005x	-88.52%
2015-12-31	CN¥2.25 Billion ≈ $329.02 Million	CN¥92.37 Million ≈ $13.52 Million	0.041x	-80.17%
2014-12-31	CN¥994.04 Million ≈ $145.46 Million	CN¥205.93 Million ≈ $30.13 Million	0.207x	+131.95%
2013-12-31	CN¥5.31 Million ≈ $776.82K	CN¥-3.44 Million ≈ $-503.70K	-0.648x	-10996.71%
2012-12-31	CN¥-60.15 Million ≈ $-8.80 Million	CN¥351.50K ≈ $51.44K	-0.006x	+99.93%
2011-12-31	CN¥790.82K ≈ $115.72K	CN¥-6.87 Million ≈ $-1.01 Million	-8.689x	-3203.30%
2010-12-31	CN¥57.85 Million ≈ $8.46 Million	CN¥-15.21 Million ≈ $-2.23 Million	-0.263x	-122.84%
2009-12-31	CN¥100.67 Million ≈ $14.73 Million	CN¥-11.88 Million ≈ $-1.74 Million	-0.118x	-228.87%
2008-12-31	CN¥338.64 Million ≈ $49.55 Million	CN¥31.02 Million ≈ $4.54 Million	0.092x	-40.95%
2007-12-31	CN¥336.95 Million ≈ $49.31 Million	CN¥52.26 Million ≈ $7.65 Million	0.155x	-9.89%
2006-12-31	CN¥336.40 Million ≈ $49.23 Million	CN¥57.90 Million ≈ $8.47 Million	0.172x	+195.38%
2005-12-31	CN¥329.66 Million ≈ $48.24 Million	CN¥-59.49 Million ≈ $-8.71 Million	-0.180x	+60.83%
2004-12-31	CN¥339.45 Million ≈ $49.67 Million	CN¥-156.37 Million ≈ $-22.88 Million	-0.461x	-958.22%
2003-12-31	CN¥419.38 Million ≈ $61.37 Million	CN¥22.51 Million ≈ $3.29 Million	0.054x	+59.52%
2002-12-31	CN¥522.69 Million ≈ $76.49 Million	CN¥17.59 Million ≈ $2.57 Million	0.034x	-45.02%
2001-12-31	CN¥498.41 Million ≈ $72.93 Million	CN¥30.50 Million ≈ $4.46 Million	0.061x	+222.29%
2000-12-31	CN¥500.54 Million ≈ $73.24 Million	CN¥-25.05 Million ≈ $-3.67 Million	-0.050x	-278.13%
1999-12-31	CN¥485.43 Million ≈ $71.03 Million	CN¥13.64 Million ≈ $2.00 Million	0.028x	--

About Hunan Jingfeng Pharmaceutical

SHE:000908 China Drug Manufacturers - General

Market Cap

$678.45 Million

CN¥4.64 Billion CNY

Market Cap Rank

#10346 Global

#2702 in China

Share Price

CN¥5.27

Change (1 day)

+1.54%

52-Week Range

CN¥4.58 - CN¥9.23

All Time High

CN¥16.99